Literature DB >> 12763633

Prolactin-releasing peptides.

Willis K Samson1, Meghan M Taylor, Jennifer R Baker.   

Abstract

Physiologic control of prolactin (PRL) secretion is largely dependent upon levels of dopamine accessing the adenohypophysis via the hypophysial portal vessels. However, it is clear that other factors of hypothalamic origin can modulate hormone secretion in the absence or presence of dopamine. Several neuropeptides have been identified as PRL releasing factors (PRFs) but none of these peptides appears to be a major determinant of PRL secretion in vivo. There remain uncharacterized activities in hypothalamic extracts that can alter secretion and production of the hormone. In addition, there exist a wide variety of substances (neurotransmitters, neuromodulators, neuropeptides) that can act within the hypothalamus to modify the neuroendocrine regulation of PRL secretion. These factors may not be considered true PRFs because their actions are not exerted directly at the level of the lactotroph; however, they can act in brain to stimulate PRL release in vivo and therefore might be considered PRL releasing peptides (PRPs).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763633     DOI: 10.1016/s0167-0115(03)00110-1

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

1.  Pituitary development and physiology.

Authors:  Clement C Cheung; Robert H Lustig
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 2.  The Arg-Phe-amide peptide 26RFa/glutamine RF-amide peptide and its receptor: IUPHAR Review 24.

Authors:  Jérôme Leprince; Didier Bagnol; Ronan Bureau; Shoji Fukusumi; Riccarda Granata; Shuji Hinuma; Dan Larhammar; Stefany Primeaux; Jana Sopkova-de Oliveiras Santos; Kazuyoshi Tsutsui; Kazuyoshi Ukena; Hubert Vaudry
Journal:  Br J Pharmacol       Date:  2017-09-08       Impact factor: 8.739

3.  Cocaine-mediated supersensitivity of 5-HT2A receptors in hypothalamic paraventricular nucleus is a withdrawal-induced phenomenon.

Authors:  G A Carrasco; L D Van de Kar; N R Sullivan; M Landry; F Garcia; N A Muma; G Battaglia
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

4.  Study of the role of novel RF-amide neuropeptides in affecting growth hormone secretion in a representative non-human primate (Macaca mulatta).

Authors:  Fatima Qaiser; Fazal Wahab; Muhammad Amin Wiqar; Rizwan Hashim; Jerome Leprince; Hubert Vaudry; Manuel Tena-Sempere; Muhammad Shahab
Journal:  Endocrine       Date:  2012-04-22       Impact factor: 3.633

5.  Prolactin-releasing Peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo.

Authors:  Carlos Spuch; Yolanda Diz-Chaves; Diego Pérez-Tilve; Mayte Alvarez-Crespo; Federico Mallo
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

Review 6.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

7.  Identification of neuromedin U precursor-related peptide and its possible role in the regulation of prolactin release.

Authors:  Kenji Mori; Takanori Ida; Mami Fudetani; Miwa Mori; Hiroyuki Kaiya; Jun Hino; Keiko Nakahara; Noboru Murakami; Mikiya Miyazato; Kenji Kangawa
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

8.  Prolactin and male fertility: the long and short feedback regulation.

Authors:  M K Gill-Sharma
Journal:  Int J Endocrinol       Date:  2009       Impact factor: 3.257

Review 9.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

10.  Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.

Authors:  Jack H Jhamandas; Valeri Goncharuk
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-07       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.